MADRIGAL PHARMACEUTICALS, INC. Amortization of Debt Issuance Costs and Discounts
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Amortization of Debt Issuance Costs and Discounts of $913.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-07-30
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $464.00K, a 25.07% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $449.00K, a 2.98% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $468.00K, a 2.90% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $329.00K, a 31.46% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2025 was $1.60M, a 23.22% decline from fiscal 2024.
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2024 was $2.09M, a 13.46% decline from fiscal 2023.
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2023 was $2.41M, a 202.89% increase from fiscal 2022.
- MADRIGAL PHARMACEUTICALS, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $797.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2026-06-30 | $464.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $913.00K 10-Q · filed 2026-07-30 | $1.38M derived: sum of 3 quarters · filed 2026-07-30 | $1.71M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $449.00K 10-Q · filed 2026-05-06 | $917.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.25M derived: sum of 3 quarters · filed 2026-05-06 | $1.62M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $797.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.17M derived: sum of 3 quarters · filed 2026-07-30 | $1.60M 10-K · filed 2026-02-19 |
| 2025-09-30 | $329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $700.00K derived: sum of 2 quarters · filed 2026-07-30 | $1.14M 10-Q · filed 2025-11-04 | $1.62M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $371.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $807.00K 10-Q · filed 2026-07-30 | $1.29M derived: sum of 3 quarters · filed 2026-07-30 | $1.77M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $436.00K 10-Q · filed 2026-05-06 | $918.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.40M derived: sum of 3 quarters · filed 2026-05-06 | $1.87M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $962.00K derived: sum of 2 quarters · filed 2026-02-19 | $1.43M derived: sum of 3 quarters · filed 2026-02-19 | $2.09M 10-K · filed 2026-02-19 |
| 2024-09-30 | $480.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $952.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.61M 10-Q · filed 2025-11-04 | $2.36M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $1.13M 10-Q · filed 2025-08-05 | $1.88M derived: sum of 3 quarters · filed 2026-02-19 | $2.55M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $655.00K 10-Q · filed 2025-05-01 | $1.41M derived: sum of 2 quarters · filed 2026-02-19 | $2.08M derived: sum of 3 quarters · filed 2026-02-19 | $2.64M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $753.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $1.43M derived: sum of 2 quarters · filed 2026-02-19 | $1.98M derived: sum of 3 quarters · filed 2026-02-19 | $2.41M 10-K · filed 2026-02-19 |
| 2023-09-30 | $674.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.23M derived: sum of 2 quarters · filed 2024-10-31 | $1.66M 10-Q · filed 2024-10-31 | $1.97M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $554.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $987.00K 10-Q · filed 2024-08-07 | $1.29M derived: sum of 3 quarters · filed 2025-02-26 | $1.61M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $433.00K 10-Q · filed 2024-05-07 | $739.00K derived: sum of 2 quarters · filed 2025-02-26 | $1.05M derived: sum of 3 quarters · filed 2025-02-26 | $1.23M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $619.00K derived: sum of 2 quarters · filed 2025-02-26 | $797.00K derived: sum of 3 quarters · filed 2025-02-26 | $797.00K 10-K · filed 2025-02-26 |
| 2022-09-30 | $313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $491.00K derived: sum of 2 quarters · filed 2023-11-06 | $491.00K 10-Q · filed 2023-11-06 | $491.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $178.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $178.00K 10-Q · filed 2023-08-08 | $178.00K derived: sum of 3 quarters · filed 2024-02-28 | $178.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | |||
| 2020-12-31 | $0.00 10-K/A · filed 2023-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |